Published in Int J Radiat Oncol Biol Phys on December 08, 2006
Artefacts in CBCT: a review. Dentomaxillofac Radiol (2011) 3.78
Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants? Phys Med Biol (2008) 1.37
Influence of scanning and reconstruction parameters on quality of three-dimensional surface models of the dental arches from cone beam computed tomography. Clin Oral Investig (2009) 1.19
Application of polychromatic µCT for mineral density determination. J Dent Res (2010) 1.10
Quantitative cone-beam CT imaging in radiation therapy using planning CT as a prior: first patient studies. Med Phys (2012) 1.09
Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy. Med Phys (2012) 1.06
Three-dimensional localization of impacted teeth using magnetic resonance imaging. Clin Oral Investig (2009) 1.04
Detection of dental root fractures by using cone-beam computed tomography. Dentomaxillofac Radiol (2011) 1.00
Spatial resolution in CBCT machines for dental/maxillofacial applications-what do we know today? Dentomaxillofac Radiol (2015) 0.99
Metal artifact reduction from reformatted projections for hip prostheses in multislice helical computed tomography: techniques and initial clinical results. Invest Radiol (2009) 0.98
Comparison of high-resolution and standard zoom imaging modes in cone beam computed tomography for detection of longitudinal root fracture: An in vitro study. Imaging Sci Dent (2013) 0.88
The association between complete absence of post-treatment periapical lesion and quality of root canal filling. Clin Oral Investig (2012) 0.88
Beam hardening artifacts by dental implants: Comparison of cone-beam and 64-slice computed tomography scanners. Dent Res J (Isfahan) (2013) 0.87
Beam Hardening Artifacts: Comparison between Two Cone Beam Computed Tomography Scanners. J Dent Res Dent Clin Dent Prospects (2012) 0.85
Assessment of metal artefact reduction around dental titanium implants in cone beam CT. Dentomaxillofac Radiol (2014) 0.84
Peering through the glare: using dual-energy CT to overcome the problem of metal artefacts in bone radiology. Skeletal Radiol (2014) 0.81
Accuracy of peri-implant bone evaluation using cone beam CT, digital intra-oral radiographs and histology. Dentomaxillofac Radiol (2014) 0.81
Metal artifact correction for x-ray computed tomography using kV and selective MV imaging. Med Phys (2014) 0.81
Assessment of metal artifacts in three-dimensional dental surface models derived by cone-beam computed tomography. Korean J Orthod (2014) 0.80
Diagnostic performance of cone-beam computed tomography on detection of mechanically-created artificial secondary caries. Imaging Sci Dent (2011) 0.80
Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses. Radiat Oncol (2014) 0.80
Volumetric modulated arc therapy for prostate cancer patients with hip prosthesis. Rep Pract Oncol Radiother (2013) 0.80
The use of navigation (BrainLAB Vector vision(2)) and intraoperative 3D imaging system (Siemens Arcadis Orbic 3D) in the treatment of gunshot wounds of the maxillofacial region. Oral Maxillofac Surg (2009) 0.79
The influence of amalgam fillings on the detection of approximal caries by cone beam CT: in vitro study. Dentomaxillofac Radiol (2014) 0.79
Four dimensional digital tomosynthesis using on-board imager for the verification of respiratory motion. PLoS One (2014) 0.78
A metal artifact reduction algorithm in CT using multiple prior images by recursive active contour segmentation. PLoS One (2017) 0.75
Scattered image artifacts from cone beam computed tomography and its clinical potential in bone mineral density estimation. Springerplus (2016) 0.75
Soft tissue coverage on the segmentation accuracy of the 3D surface-rendered model from cone-beam CT. Clin Oral Investig (2016) 0.75
A metal artifact reduction method for a dental CT based on adaptive local thresholding and prior image generation. Biomed Eng Online (2016) 0.75
Radiolucent Skull Clamps for Intra-Operative Imaging: A Technical Note. Cureus (2017) 0.75
The role of actigraphy in the study of sleep and circadian rhythms. Sleep (2003) 10.70
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 6.98
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol (2005) 4.00
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys (2004) 3.21
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2005) 3.19
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys (2007) 2.80
Mortality after cure of testicular seminoma. J Clin Oncol (2004) 2.53
Ultrasound-based localization. Semin Radiat Oncol (2005) 2.52
The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer (2003) 2.46
Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys (2007) 2.35
Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys (2009) 2.27
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2008) 2.22
Objective assessment of deformable image registration in radiotherapy: a multi-institution study. Med Phys (2008) 2.15
Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys (2010) 2.09
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy. Brachytherapy (2012) 2.05
Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol (2008) 1.90
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.87
Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.85
Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.85
Dosimetry tools and techniques for IMRT. Med Phys (2011) 1.84
Four-dimensional cone beam CT with adaptive gantry rotation and adaptive data sampling. Med Phys (2007) 1.84
Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.75
The M. D. Anderson proton therapy system. Med Phys (2009) 1.75
Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.73
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys (2010) 1.70
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys (2007) 1.69
Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One (2012) 1.67
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.63
Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys (2011) 1.59
DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer (2014) 1.56
Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer. Phys Med Biol (2008) 1.51
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys (2005) 1.49
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.49
Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet (2011) 1.49
Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer (2013) 1.48
Protective effect of a coffee preparation (Nescafe pure) against carbon tetrachloride-induced liver fibrosis in rats. Clin Nutr (2010) 1.48
Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys (2008) 1.47
Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J (2012) 1.47
Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats. Diagn Microbiol Infect Dis (2003) 1.45
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys (2007) 1.41
Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard? J Oncol (2010) 1.41
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys (2007) 1.40
Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol (2004) 1.36
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol (2007) 1.35
Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol (2012) 1.34
Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.33
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.32
Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain. J Neurosci (2012) 1.31
A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys (2011) 1.31
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol (2012) 1.28
Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys (2008) 1.26
Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom. Med Phys (2007) 1.26
miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun (2011) 1.25
Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys (2012) 1.23
Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol (2007) 1.23
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model. Int J Radiat Oncol Biol Phys (2010) 1.21
Automatic registration of the prostate for computed-tomography-guided radiotherapy. Med Phys (2003) 1.21
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.20
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer (2006) 1.20
Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose. Int J Radiat Oncol Biol Phys (2011) 1.19
A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys (2012) 1.19
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.17
Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles). Tuberculosis (Edinb) (2007) 1.16
Experimental characterization of the low-dose envelope of spot scanning proton beams. Phys Med Biol (2010) 1.16
Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol (2009) 1.16
Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams. Phys Med Biol (2010) 1.15
Automatic segmentation of whole breast using atlas approach and deformable image registration. Int J Radiat Oncol Biol Phys (2008) 1.15
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology (2009) 1.15
A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med Phys (2006) 1.14
Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys (2012) 1.13
Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys (2003) 1.12
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys (2011) 1.11
Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis (2013) 1.11
Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.11
Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials (2011) 1.11
Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero. Proc Natl Acad Sci U S A (2008) 1.09